http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130067551-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bce7de965c4fdb43603183462b4cb867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6788a53ffde03ce5039e2988a9ba30e1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 |
| filingDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c94054c3bccfb07b8db0f521a1f32031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd5e67c120cb13b696116144a3d97bcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0385362b68b7054a206518de67f351da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d88b5f6d3f5a50464209fa203e699c2 |
| publicationDate | 2013-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130067551-A |
| titleOfInvention | Diabetic treatment composition |
| abstract | The present invention relates to a composition for treating diabetes using decosinol angelate as an active ingredient, and to a composition for treating diabetes having an effect of treating diabetes by reducing blood sugar using decosinol angelate. The composition for treating diabetes of the present invention increases glucose drop, diet and feed efficiency, increases activation of AMP-Activated Protein Kinase and expression of glucose transporter-4 in muscle tissue, thereby transporting glucose. Glucose transporter-4 transports glucose into muscle tissue and is effective in treating diabetes. In addition, the diabetic therapeutic composition of the present invention increases the inactivation of AMP-Activated Protein Kinase and the expression of Glucose transporter-2 in the pancreatic beta cells, thereby causing the pancreatic beta cells to respond to blood glucose levels. By secreting insulin it has the effect of treating diabetes. In addition, the diabetic therapeutic composition of the present invention has the effect of restoring the beta-cell damage of the pancreas due to diabetes, and even if a large amount is used, there is no cytotoxicity and thus has the effect of increasing the survival rate of renal proximal cells by high glucose concentration. Bar is very useful as a diabetes treatment. |
| priorityDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.